Contact Information: Contacts: Cris Larson Chief Financial Officer (775) 832-8505 David Carey Lazar Partners Investor Relations (212) 867-1768
PDL BioPharma to Host Fourth-Quarter and Full-Year 2008 Financial Results Conference Call on March 2, 2009
| Source: PDL BioPharma
INCLINE VILLAGE, NV--(Marketwire - February 20, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ : PDLI ) today announced that it will release its financial results for the
fourth quarter and full year 2008 following the close of the U.S. financial
markets on Monday, March 2, 2009. PDL will hold a conference call to
discuss these financial results and provide an update on company activities
at 1:30 p.m. Pacific time, 4:30 p.m. Eastern time on March 2, 2009.
To participate in this teleconference, please dial 888-727-7622 fifteen
minutes before the conference is scheduled to begin. Callers outside of the
U.S. should dial 913-312-0392. The participant passcode is 2182491. The
call will also be Webcast live at www.pdl.com. A replay of the call will be
available for two weeks on the company's Web site, or until March 16 by
dialing 888-203-1112. Callers outside of the U.S. should dial
719-457-0820. The replay passcode is 2182491.
About PDL BioPharma
PDL BioPharma, Inc. pioneered the humanization of monoclonal antibodies
and, by doing so, enabled the discovery of a new generation of targeted
treatments for cancer and autoimmune diseases. This press release and
further information about PDL BioPharma, Inc. can be found at: www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of
PDL BioPharma, Inc.